SAA combined with prednisone exhibited therapeutic and antiproteinuric effects on adriamycin-induced minimal change disease rat model through PPARγ/Angptl4 and Nrf2/Heme oxygenase-1 (HO-1) pathways (191). The gene discussed is HMOX1; the disease is lipoid nephrosis.